ObsEva SA Reports Consistent Long-Term Findings from Phase 2b EDELWEISS trial of Linzagolix for Endometriosis-Associated Pain
May 03, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – May 3, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and...
ObsEva SA Reports Further Infant Follow-up Data from IMPLANT2 Trial Echoing Favorable Safety Profile of Nolasiban in IVF
April 29, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – April 29 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
Update: ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial
January 23, 2019 03:28 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – January 23, 2019 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
ObsEva SA Reports Initial Good Safety of OBE022 in Pregnant Women with Preterm Labour and Announces Start of Part B of the PROLONG Trial
January 23, 2019 01:00 ET
|
ObsEva SA
Geneva, Switzerland and Boston, MA – January 23, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel...
New Research Shows How Diagnostic Testing Can Advance the Identification and Treatment of Harmful Drug-Drug Interactions
December 05, 2018 09:55 ET
|
Aegis Sciences Corporation
NASHVILLE, Tenn., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative testing and consulting services to providers,...
Canntab Enters Into a Binding Term Sheet With Leading Orthopaedic Surgeon Dr. Don Garbuz, M.D. for a Clinical Research Trial of Canntab’s Tablets
December 05, 2018 08:00 ET
|
Canntab Therapeutics Limited
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE U.S. Partnership formed with Dr. Don Garbuz, an award winning orthopaedic surgeon and medical researcher, credited with...
EU Parliament Intervention Threatens Right to Fair Trial in Berta Cáceres Case in Honduras, Says Lawyer Robert Amsterdam
November 27, 2018 09:42 ET
|
Amsterdam and Partners
LONDON, Nov. 27, 2018 (GLOBE NEWSWIRE) -- On Thursday 29 November 2018 a Honduran criminal court is expected to issue a ruling against eight individuals accused of involvement in the 2016 murder of...
New Research Reveals the Prevalence of Drug-Drug Interactions and the Economic Impact on the Healthcare System
November 05, 2018 14:00 ET
|
Aegis Sciences Corporation
Studies show an alarming prevalence of concurrent ingestion of interacting substances by patients and that providing physicians with clear, objective information leads to a reduction of interactions...
Oblato acquires all rights to glioblastoma drug from OMRF
October 29, 2018 11:21 ET
|
Oklahoma Medical Research Foundation
OKLAHOMA CITY, Oct. 29, 2018 (GLOBE NEWSWIRE) -- Oblato, Inc., has acquired all rights from the Oklahoma Medical Research Foundation to OKN-007, an investigational drug for the treatment of...
CTI Clinical Trial and Consulting Services Announces Acquisition of Eurotrials
December 07, 2017 15:00 ET
|
CTI Clinical Trial & Consulting Services
COVINGTON, Ky., Dec. 07, 2017 (GLOBE NEWSWIRE) -- CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of...